跳至主要内容
临床试验/NCT02979223
NCT02979223已完成2 期

Comparison the Efficacy Depending on the Order of the Sequential Combination Method Using Sodium Picosulfate and Magnesium Citrate (PMC) and PEG With Ascorbic Acid for Bowel Preparation (The Phase II Prospective Randomized Clinical Trial)

National Cancer Center, Korea1 个研究点 分布在 1 个国家目标入组 142 人开始时间: 2016年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
142
试验地点
1
主要终点
Successful bowel preparation (Excellent and Good in Aronchick bowel preparation score)

研究概览

简要总结

The aim of this study is to compare the efficacy depending on the order of the sequential combination method using sodium picosulfate and magnesium citrate (PMC) and PEG with ascorbic acid for bowel preparation.

The investigators designed this study as a phase II prospective randomized parallel arm clinical trial. 71 participant will be enrolled in each group (142 in total).

The primary outcome is the efficacy of bowel preparation. secondary outcomes are tolerability, side effect of the drugs, polyp detection rate and adenoma detection rate.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Single (Investigator)

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age: 20-75 Patients who visited the outpatient clinic for colonoscopy Patients who agreed to participate in this study

排除标准

  • pregnancy, breast feeding stage 3-5 chronic kidney disease (glomerular filtration rate < 60 mL/min/1.73m2), inability to maintain adequate fluid intake, pre-existing electrolyte disturbances, symptomatic congestive heart failure, recent (within < 6 months) symptomatic ischemic heart disease (unstable angina or myocardial infarction).
  • toxic megacolon active colitis Allergic to drug altered mental status Nausea and vomiting Hyperphosphatemia glucose-6-phosphate dehydrogenase deficiency Hereditary Phenylketonuria Patients with a history of colon surgery Abdominal operation within 6 months

研究组 & 干预措施

PMC/PEG-Asc

Experimental

Picolyte 1 bottle/170cc at one day before colonoscopy, 7 PM. And then, Intake Coolprep 1L at the day of colonoscopy, 5 AM

干预措施: sodium picosulfate and magnesium citrate, polyethylene glycol with ascorbic acid (Drug)

PEG-Asc/PMC

Active Comparator

Intake Coolprep 1L at one day before colonoscopy, 7 PM. And then, Intake Picolyte 1 bottle/170cc at the day of colonoscopy, 5AM

干预措施: sodium picosulfate and magnesium citrate, polyethylene glycol with ascorbic acid (Drug)

结局指标

主要结局

Successful bowel preparation (Excellent and Good in Aronchick bowel preparation score)

时间窗: during colonoscopy

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Byung Chang KIM

Principle investigator

National Cancer Center, Korea

研究点 (1)

Loading locations...

相似试验